EDGAR Filing Documents for 0001104659-17-069461

Form 8-K - Current report:

SEC Accession No. 0001104659-17-069461

Filing Date

2017-11-17

Accepted

2017-11-17 16:31:53

Documents

Period of Report

2017-11-14

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	a17-27210_18k.htm	8-K	39469
2	EX-4.1	a17-27210_1ex4d1.htm	EX-4.1	145156
3	EX-10.1	a17-27210_1ex10d1.htm	EX-10.1	305143
4	EX-10.2	a17-27210_1ex10d2.htm	EX-10.2	186677
5	EX-10.3	a17-27210_1ex10d3.htm	EX-10.3	74919
6	EX-99.1	a17-27210_1ex99d1.htm	EX-99.1	12254
7	GRAPHIC	g272101mmi001.jpg	GRAPHIC	1991
	Complete submission text file	0001104659-17-069461.txt		767824

Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142

Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343

LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)